GE HealthCare Emphasizes AI with New M&A

The Chicago, IL-based firm has signed an agreement to acquire the clinical artificial intelligence business from Intelligent Ultrasound for $51 million.

Omar Ford

July 18, 2024

1 Min Read
Image Credit: Userba011d64_201 via iStock / Getty Images

GE HealthCare is making an acquisition to expand its portfolio of artificial intelligence-enabled devices in imaging.

The Chicago, IL-based company said it has entered into an agreement to acquire the clinical AI business from Intelligent Ultrasound for $51 million.

Intelligent Ultrasound specializes in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient. Intelligent Ultrasound said it  has pioneered the ScanNav Assist AI technology, which powers SonoLystlive and SonoLyst X/IR, available on GE HealthCare’s Voluson Expert and Voluson Signature ultrasound devices.

"We are pleased to bring innovative technology from Intelligent Ultrasound into GE HealthCare’s Ultrasound portfolio, allowing us to fully integrate these solutions into our systems to help clinicians improve workflow, reduce repetitive tasks, and simplify exams,” said Phil Rackliffe, president and CEO of Ultrasound and Image Guided Therapies, GE HealthCare said in a release. “This technology and the experts who developed it will help enhance our portfolio of AI-enabled devices and accelerate our pace of development of next-generation AI tools.”

The deal comes a little more than a year after GE HealthCare added another piece to its growing AI puzzle by acquiring Caption Health. The San Mateo, CA-based company specializes in using AI to assist in conducting ultrasound scans.

Related:GE Healthcare to Stand on Its Own

In September of last year, Jan Makela, President and CEO of imaging at GE HealthCare, was a guest on the Let’s Talk Medtech podcast to discuss the company’s plans for imaging and AI.

You can access the episode below.

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like